Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence and Bioavailability Study of Advil Tablet (Mini) vs Advil Tablet in Healthy Adults
NCT07345130Phase 1Completed
- Sponsor
- Haleon
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain and fever (6 arms), sponsored by Haleon. Primary endpoints: Maximum Observed Post-dose Concentration at 24 hours, Area Under the Plasma Concentration Versus Time Curve Calculated from Time 0 to the Last Measurable Sampling Time Point at 24 hours and 1 more. Started Dec 2025; status: completed.
02
Drugs
ibuprofen
03
Conditions
painfever
Beyond the preview
Go deeper on NCT07345130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07345130.